1 |
(-)-trans-delta-9-tetrahydrocannabinol |
Dronabinol |
1件: D00306 D00306 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 1件: 13 💬 |
2 |
(im) avonex® |
- |
- |
- |
- |
013 1件: 13 💬 |
3 |
(r) 3-(5-dimethylcarbamoyl-pent-1-enyl)-n-(2-hydroxy-1- methylethyl) benzamide |
- |
- |
- |
- |
013 1件: 13 💬 |
4 |
0,5 mg fingolimod |
Fingolimod |
1件: D10001 D10001 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
5 |
0.25 mg rpc1063 |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
6 |
0.25mg rpc1063 |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
7 |
0.5 mg rpc1063 |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
8 |
0.5mg rpc1063 |
- |
- |
- |
- |
013 1件: 13 💬 |
9 |
1 - andrographis paniculata p/st extract |
- |
- |
- |
- |
013 1件: 13 💬 |
10 |
1 mg rpc1063 |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
11 |
1% steroid cream |
- |
- |
- |
- |
013 1件: 13 💬 |
12 |
1-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1h-3-benzazepin-7-yl)oxy]-3-pyridinyl}-2-pyrrolidinone |
- |
- |
- |
- |
013 1件: 13 💬 |
13 |
1.0mg rpc1063 |
- |
- |
- |
- |
013 1件: 13 💬 |
14 |
10 milligram (mg) fampridine-sr (4-aminopyridine, 4-ap) |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
15 |
10000iu vitamin d |
Vitamin D |
- |
- |
- |
013 1件: 13 💬 |
16 |
11c-acetate |
Acetate |
- |
- |
- |
013 3件: 13, 86, 88 💬 |
17 |
11c-pbr28 |
- |
- |
- |
- |
006 2件: 6, 13 💬 |
18 |
11c-pib |
- |
- |
- |
- |
006 2件: 6, 13 💬 |
19 |
13-pcv booster |
- |
- |
- |
- |
013 1件: 13 💬 |
20 |
13-valent pneumococcal conjugate vaccine (13-pcv) |
- |
- |
- |
- |
013 1件: 13 💬 |
21 |
1393641-34-3 |
- |
- |
- |
- |
013 1件: 13 💬 |
22 |
15 mg fampridine-sr (4-aminopyridine, 4-ap) |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
23 |
18f-dpa-714 and 18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
013 1件: 13 💬 |
24 |
18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
005 12件: 5, 6, 7, 13, 41, 46, 53, 84, 85, 96, 127, 300 💬 |
25 |
18f-pm-pbb3 |
- |
- |
- |
- |
013 1件: 13 💬 |
26 |
19 nor vitamin d |
Vitamin D |
- |
- |
- |
013 1件: 13 💬 |
27 |
2 - excipients |
- |
- |
- |
- |
013 1件: 13 💬 |
28 |
2-(2-(2-amino-9h-purin-9-yl)ethyl)-1,3-propanediol diacetate ester |
- |
- |
- |
- |
013 1件: 13 💬 |
29 |
2-cda |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
30 |
2-cda, 2-chloro-2'-deoxy-beta-d-adenosine |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
31 |
2-cda, 2-chloro-2'-deoxy-ß-d-adenosine |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
32 |
2-cda, 2-chloro-2?-deoxy-beta-d-adenosine |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
33 |
2-cda, 2-chloro-2?-deoxy-ß-d-adenosine |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
34 |
2-cda, 2-chloro-2’-deoxy-beta-d-adenosine |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
35 |
2-cda, 2-chloro-2’-deoxy-ß-d-adenosine |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
36 |
2-chloro-2'-deoxy-beta-d-adenosine (2-cda) |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
37 |
2-chloro-2'-deoxy-ß-d-adenosine (2-cda) |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
38 |
2-chloro-2'-deoxyadenosine (2-cda) |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
39 |
2-chloro-2'-deoxyadenosine, 2cda |
- |
- |
- |
- |
013 1件: 13 💬 |
40 |
2-chloro-2?-deoxy-beta-d-adenosine |
Adenosine |
1件: D00045 D00045 💬 |
ADORA1 4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism 12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
41 |
2-chloro-2?-deoxy-ß-d-adenosine |
Adenosine |
1件: D00045 D00045 💬 |
ADORA1 4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism 12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
42 |
2-chloro-2’-deoxy-beta-d-adenosine |
Adenosine |
1件: D00045 D00045 💬 |
ADORA1 4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism 12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
43 |
2-chloro-2’-deoxy-beta-d-adenosine (2-cda) |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
44 |
2-chloro-2’-deoxy-ß-d-adenosine |
Adenosine |
1件: D00045 D00045 💬 |
ADORA1 4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism 12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
45 |
2-chloro-2’-deoxy-ß-d-adenosine (2-cda) |
Adenosine |
2件: D00045 D00045, D01370 D01370 💬 |
ADORA1 5件: ADORA1, ADORA2A, ADORA2B, ADORA3, RRM1 💬 |
Alcoholism 17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
46 |
2-chloro-2’-deoxyadenosine (2-cda) |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
47 |
20 mg fampridine-sr (4-aminopyridine, 4-ap) |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
48 |
20 mg ga |
- |
- |
- |
- |
013 1件: 13 💬 |
49 |
20 mg mitoq |
- |
- |
- |
- |
013 1件: 13 💬 |
50 |
200106 or emd 28162 |
- |
- |
- |
- |
013 1件: 13 💬 |
51 |
20mg/0.5ml ga |
- |
- |
- |
- |
013 1件: 13 💬 |
52 |
20mg/0.5ml glatiramer acetate |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
53 |
23-ppv |
- |
- |
- |
- |
013 1件: 13 💬 |
54 |
23-valent pneumococcal polysaccharide vaccine |
- |
- |
- |
- |
013 3件: 13, 46, 53 💬 |
55 |
23-valent pneumococcal polysaccharide vaccine (23-ppv) |
- |
- |
- |
- |
013 1件: 13 💬 |
56 |
25oh-vitamin d |
Vitamin D |
- |
- |
- |
013 1件: 13 💬 |
57 |
2b3-201 |
- |
- |
- |
- |
013 1件: 13 💬 |
58 |
3 mg melatonin |
Melatonin |
1件: D08170 D08170 💬 |
MTNR1A 2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
59 |
3,4-diaminopyridine |
- |
- |
- |
- |
011 3件: 11, 12, 13 💬 |
60 |
4-aminopyridine |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
003 2件: 3, 13 💬 |
61 |
4-ap |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
62 |
4.5 mg naltrexone |
Naltrexone |
2件: D02095 D02095, D05113 D05113 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
63 |
40 mg ga |
- |
- |
- |
- |
002 2件: 2, 13 💬 |
64 |
40 mg glatiramer acetate |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
002 2件: 2, 13 💬 |
65 |
40 mg glatiramer acetato |
Glatiramer |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
66 |
40mg of mitoq |
- |
- |
- |
- |
013 1件: 13 💬 |
67 |
5 mg melatonin |
Melatonin |
1件: D08170 D08170 💬 |
MTNR1A 2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
68 |
5000iu vitamin d |
Vitamin D |
- |
- |
- |
013 1件: 13 💬 |
69 |
52069.00.01 |
- |
- |
- |
- |
013 1件: 13 💬 |
70 |
9060x |
- |
- |
- |
- |
013 2件: 13, 149 💬 |
71 |
95% pure ecgc capsules 200mg |
- |
- |
- |
- |
013 1件: 13 💬 |
72 |
[11c]flumazenil |
Flumazenil |
1件: D00697 D00697 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
013 1件: 13 💬 |
73 |
[123i]clinde |
- |
- |
- |
- |
006 2件: 6, 13 💬 |
74 |
[14c]-rpc1063 solution (0.1 mg/ml) for oral administration |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
75 |
[18f] pbr06 |
- |
- |
- |
- |
006 2件: 6, 13 💬 |
76 |
[18f]-feppa |
- |
- |
- |
- |
006 2件: 6, 13 💬 |
77 |
[18f]dpa-714 |
- |
- |
- |
- |
013 1件: 13 💬 |
78 |
[18f]florbetapir and pet imaging |
- |
- |
- |
- |
013 1件: 13 💬 |
79 |
[c-11]methylreboxetine |
- |
- |
- |
- |
013 1件: 13 💬 |
80 |
[c-11]pbr28 |
- |
- |
- |
- |
013 1件: 13 💬 |
81 |
[c11]pk-1195 pet scan |
- |
- |
- |
- |
013 1件: 13 💬 |
82 |
[f-18]pbr06 |
- |
- |
- |
- |
013 2件: 13, 17 💬 |
83 |
[f-18]sdm-8 |
- |
- |
- |
- |
013 1件: 13 💬 |
84 |
[formistin 10 mg] |
- |
- |
- |
- |
013 1件: 13 💬 |
85 |
[md1003] |
- |
- |
- |
- |
013 1件: 13 💬 |
86 |
[metilprednisolone] |
- |
- |
- |
- |
013 1件: 13 💬 |
87 |
[omb157] |
- |
- |
- |
- |
013 1件: 13 💬 |
88 |
[tachipirina cpr 500mg] |
- |
- |
- |
- |
013 1件: 13 💬 |
89 |
[zr-89]oxine-labeled leukocytes pet/mr |
Oxyquinoline |
1件: D05321 D05321 💬 |
- |
- |
013 1件: 13 💬 |
90 |
A4i antagonist |
- |
- |
- |
- |
013 1件: 13 💬 |
91 |
Ab1010 |
- |
- |
- |
- |
002 6件: 2, 5, 6, 13, 46, 96 💬 |
92 |
Abatacept |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
93 |
Abobotulinumtoxin a |
- |
- |
- |
- |
013 1件: 13 💬 |
94 |
Abr-215062 |
- |
- |
- |
- |
013 1件: 13 💬 |
95 |
Abr-215062 sodium salt |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
96 |
Abt-555 |
- |
- |
- |
- |
013 1件: 13 💬 |
97 |
Abt-874/human monoclonal antibody against il-12 |
- |
- |
- |
- |
013 1件: 13 💬 |
98 |
Abx-1431 |
ABX-1431 |
- |
- |
- |
013 1件: 13 💬 |
99 |
Abx-1431 hcl |
ABX-1431 |
- |
- |
- |
013 1件: 13 💬 |
100 |
Acetaminophen |
Acetaminophen |
1件: D00217 D00217 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
011 14件: 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
101 |
Acetaminophen tab 650mg |
Acetaminophen |
1件: D00217 D00217 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
102 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
103 |
Acetazolamide |
Acetazolamide |
2件: D00218 D00218, D01196 D01196 💬 |
CA1 13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 |
Bile secretion 7件: Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation |
013 6件: 13, 90, 115, 155, 225, 230 💬 |
104 |
Acetylcysteine |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
006 16件: 6, 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬 |
105 |
Acetylsalicylic acid |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 4件: 13, 46, 51, 210 💬 |
106 |
Acetylsalicylic acid at 1st visit, |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
107 |
Aciclovir |
Acyclovir |
1件: D00222 D00222 💬 |
- |
- |
013 2件: 13, 60 💬 |
108 |
Aclasta |
- |
- |
- |
- |
013 3件: 13, 271, 274 💬 |
109 |
Aclasta 5 mg infusionslösung |
- |
- |
- |
- |
013 1件: 13 💬 |
110 |
Aclasta 5mg solution for infusion |
- |
- |
- |
- |
013 1件: 13 💬 |
111 |
Act |
- |
- |
- |
- |
013 1件: 13 💬 |
112 |
Act-1 |
- |
- |
- |
- |
013 1件: 13 💬 |
113 |
Act-128800 |
Ponesimod |
1件: D11215 D11215 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
114 |
Act-128800 dose 1 |
Ponesimod |
1件: D11215 D11215 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
115 |
Act-128800 dose 2 |
Ponesimod |
1件: D11215 D11215 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
116 |
Act-128800 dose 3 |
Ponesimod |
1件: D11215 D11215 💬 |
S1PR1 1件: S1PR1 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 1件: 13 💬 |
117 |
Acth |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 5件: 13, 66, 145, 193, 222 💬 |
118 |
Acthar |
- |
- |
- |
- |
002 9件: 2, 13, 14, 46, 49, 50, 66, 84, 222 💬 |
119 |
Acthar gel |
- |
- |
- |
- |
013 6件: 13, 46, 49, 50, 84, 222 💬 |
120 |
Acthar gel (acth) |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 1件: 13 💬 |
121 |
Active comparator receiving extavia® |
- |
- |
- |
- |
013 1件: 13 💬 |
122 |
Active control |
- |
- |
- |
- |
013 1件: 13 💬 |
123 |
Actos (pioglitazone) |
Pioglitazone |
2件: D00945 D00945, D08378 D08378 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
013 1件: 13 💬 |
124 |
Acyclovir |
Acyclovir |
1件: D00222 D00222 💬 |
- |
- |
013 2件: 13, 28 💬 |
125 |
Adderall xr |
- |
- |
- |
- |
013 1件: 13 💬 |
126 |
Adderall xr 10 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
127 |
Adderall xr 5mg |
- |
- |
- |
- |
013 1件: 13 💬 |
128 |
Adenosine |
Adenosine |
1件: D00045 D00045 💬 |
ADORA1 4件: ADORA1, ADORA2A, ADORA2B, ADORA3 💬 |
Alcoholism 12件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 3件: 13, 58, 65 💬 |
129 |
Adrenocorticotropic hormone |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 3件: 13, 50, 84 💬 |
130 |
Adrenocorticotropic hormone (acth) gel (h.p. acthar®) |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 1件: 13 💬 |
131 |
Ads-5102 |
- |
- |
- |
- |
006 2件: 6, 13 💬 |
132 |
Ads-5102, 137 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
133 |
Ads-5102, 274 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
134 |
Aert, (r)-baclofen |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
135 |
Agee cream |
- |
- |
- |
- |
013 1件: 13 💬 |
136 |
Ahsc |
- |
- |
- |
- |
013 1件: 13 💬 |
137 |
Aimspro |
- |
- |
- |
- |
013 2件: 13, 51 💬 |
138 |
Ain |
- |
- |
- |
- |
013 1件: 13 💬 |
139 |
Ain457 |
- |
- |
- |
- |
013 7件: 13, 37, 41, 46, 56, 96, 271 💬 |
140 |
Alanine |
Alanine |
1件: D00012 D00012 💬 |
- |
- |
006 4件: 6, 13, 298, 299 💬 |
141 |
Albumin (human) 25%, united states pharmacopeia (usp) |
- |
- |
- |
- |
013 2件: 13, 14 💬 |
142 |
Albuterol |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
012 8件: 12, 13, 86, 89, 113, 231, 256, 299 💬 |
143 |
Alcohol |
Ethanol |
4件: D00068 D00068, D02798 D02798, D04855 D04855, D06542 D06542 💬 |
- |
- |
013 4件: 13, 58, 279, 298 💬 |
144 |
Alemtuzumab |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 16件: 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
145 |
Alemtuzumab (gz402673) |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
146 |
Alemtuzumab 12 mg |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
147 |
Alemtuzumab 24 mg |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
148 |
Alemtuzumab gz402673 |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
149 |
Alemtuzumab immunotherapy |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
150 |
Alemtuzumab injection |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
151 |
Alemtuzumab injection [lemtrada] |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
152 |
Alfuzosin |
Alfuzosin |
2件: D01692 D01692, D07124 D07124 💬 |
ADRA1A 1件: ADRA1A 💬 |
AMPK signaling pathway 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
153 |
Alks 8700 |
- |
- |
- |
- |
013 1件: 13 💬 |
154 |
Alks 8700 delayed release (dr) |
- |
- |
- |
- |
013 1件: 13 💬 |
155 |
Alks 8700 delayed release (dr) capsule |
- |
- |
- |
- |
013 1件: 13 💬 |
156 |
Allogeneic fecal microbiota |
- |
- |
- |
- |
013 1件: 13 💬 |
157 |
Allogeneic human umbilical cord tissue-derived mesenchymal stem cells |
- |
- |
- |
- |
013 1件: 13 💬 |
158 |
Alpha lipoic acid |
Lipoic acid |
2件: D00048 D00048, D00086 D00086 💬 |
- |
- |
013 1件: 13 💬 |
159 |
Alpha-lipoic acid |
Lipoic acid |
2件: D00048 D00048, D00086 D00086 💬 |
- |
- |
002 2件: 2, 13 💬 |
160 |
Alpha1-antitrypsin |
- |
- |
- |
- |
013 1件: 13 💬 |
161 |
Altri farmaci del sistema nervoso |
- |
- |
- |
- |
013 1件: 13 💬 |
162 |
Alxn1210 |
- |
- |
- |
- |
002 5件: 2, 11, 13, 62, 109 💬 |
163 |
Amantadine |
Amantadine |
2件: D00777 D00777, D07441 D07441 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 4件: 6, 8, 13, 127 💬 |
164 |
American ginseng |
Ginseng |
1件: D06772 D06772 💬 |
- |
- |
013 1件: 13 💬 |
165 |
American ginseng extract ht-1001 |
Ginseng |
1件: D06772 D06772 💬 |
- |
- |
013 1件: 13 💬 |
166 |
Amiloride |
Amiloride |
2件: D00649 D00649, D07447 D07447 💬 |
SCNN1A 3件: SCNN1A, SCNN1B, SCNN1G 💬 |
Aldosterone-regulated sodium reabsorption 2件: Aldosterone-regulated sodium reabsorption, Taste transduction |
013 3件: 13, 225, 299 💬 |
167 |
Amiloride hydrochloride |
Amiloride |
2件: D00649 D00649, D07447 D07447 💬 |
SCNN1A 3件: SCNN1A, SCNN1B, SCNN1G 💬 |
Aldosterone-regulated sodium reabsorption 2件: Aldosterone-regulated sodium reabsorption, Taste transduction |
013 1件: 13 💬 |
168 |
Amiloride hydrochloride, 2 h2o |
Amiloride |
2件: D00649 D00649, D07447 D07447 💬 |
SCNN1A 3件: SCNN1A, SCNN1B, SCNN1G 💬 |
Aldosterone-regulated sodium reabsorption 2件: Aldosterone-regulated sodium reabsorption, Taste transduction |
013 1件: 13 💬 |
169 |
Amilostad |
- |
- |
- |
- |
013 1件: 13 💬 |
170 |
Amilostad hct |
- |
- |
- |
- |
013 1件: 13 💬 |
171 |
Amilostad hct tablets |
- |
- |
- |
- |
013 1件: 13 💬 |
172 |
Ampyra |
- |
- |
- |
- |
006 2件: 6, 13 💬 |
173 |
Amyvid |
- |
- |
- |
- |
013 2件: 13, 127 💬 |
174 |
Amyvid radiopharmaceutical |
- |
- |
- |
- |
013 1件: 13 💬 |
175 |
An100226 |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
176 |
An100226, bg00002 |
- |
- |
- |
- |
013 1件: 13 💬 |
177 |
Anakinra |
Anakinra |
1件: D02934 D02934 💬 |
IL1R1 2件: IL1R1, IL1R2 💬 |
Amoebiasis 15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer |
002 17件: 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 💬 |
178 |
Androgel 1 % topical gel |
- |
- |
- |
- |
013 1件: 13 💬 |
179 |
Androgel 10 grams of gel containing 100 mg of testosterone |
Testosterone |
6件: D00075 D00075, D00957 D00957, D00958 D00958, D00959 D00959, D06085 D06085, D06087 D06087 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
013 1件: 13 💬 |
180 |
Andrographolides |
- |
- |
- |
- |
013 1件: 13 💬 |
181 |
Anesthetic topical adhesive synera |
- |
- |
- |
- |
013 1件: 13 💬 |
182 |
Ank-700 |
- |
- |
- |
- |
013 1件: 13 💬 |
183 |
Anti lp40 antibody, subclass igg4 la294 |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
184 |
Anti-cd25 humanized monoclonal antibody |
- |
- |
- |
- |
013 1件: 13 💬 |
185 |
Anti-cd52 monoclonal antibody |
- |
- |
- |
- |
013 1件: 13 💬 |
186 |
Anti-il-12 |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
187 |
Anti-thymocyte globulin |
- |
- |
- |
- |
011 18件: 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬 |
188 |
Anticholinergic medication |
- |
- |
- |
- |
013 1件: 13 💬 |
189 |
Anticuerpo monoclonal anti-lingo-1 humano |
- |
- |
- |
- |
013 1件: 13 💬 |
190 |
Antihistamine |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
191 |
Antimycotic |
- |
- |
- |
- |
013 1件: 13 💬 |
192 |
Antithymocyte |
- |
- |
- |
- |
013 1件: 13 💬 |
193 |
Antithymocyte gamma immunoglobulin |
- |
- |
- |
- |
013 1件: 13 💬 |
194 |
Antithymocyte immunoglobulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 2件: 13, 96 💬 |
195 |
Antithymocyte immunoglobulin (rabbit) |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 2件: 13, 96 💬 |
196 |
Anxiety/depression and work and activities |
- |
- |
- |
- |
013 1件: 13 💬 |
197 |
Ap |
- |
- |
- |
- |
002 4件: 2, 6, 13, 299 💬 |
198 |
Apitox - pure honeybee toxin |
- |
- |
- |
- |
013 1件: 13 💬 |
199 |
Arbaclofen |
Arbaclofen |
1件: D09791 D09791 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 2件: 13, 206 💬 |
200 |
Arbaclofen er tablets |
Arbaclofen |
1件: D09791 D09791 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
201 |
Arbaclofen extended release tablets |
Arbaclofen |
1件: D09791 D09791 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
202 |
Arbaclofen placarbil |
Arbaclofen |
2件: D08861 D08861, D09791 D09791 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
203 |
Arbaclofen placarbil 15 mg bid |
Arbaclofen |
2件: D08861 D08861, D09791 D09791 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
204 |
Arbaclofen placarbil 30 mg bid |
Arbaclofen |
2件: D08861 D08861, D09791 D09791 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
205 |
Arbaclofen placarbil 45 mg bid |
Arbaclofen |
2件: D08861 D08861, D09791 D09791 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
206 |
Aricept |
- |
- |
- |
- |
006 4件: 6, 13, 78, 124 💬 |
207 |
Aricept 10 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
208 |
Aricept 10 mg filmdragerade tabletter |
- |
- |
- |
- |
013 1件: 13 💬 |
209 |
Aricept 5 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
210 |
Aricept 5 mg filmdragerade tabletter |
- |
- |
- |
- |
013 1件: 13 💬 |
211 |
Arm 1 - geh120714 (18f) injection |
- |
- |
- |
- |
013 1件: 13 💬 |
212 |
Armodafinil |
Armodafinil |
1件: D03215 D03215 💬 |
SLC6A3 1件: SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
006 3件: 6, 13, 84 💬 |
213 |
Arn-6039 |
- |
- |
- |
- |
013 1件: 13 💬 |
214 |
Arzerra |
- |
- |
- |
- |
013 1件: 13 💬 |
215 |
Arzerra® |
- |
- |
- |
- |
013 1件: 13 💬 |
216 |
Asa |
- |
- |
- |
- |
013 4件: 13, 96, 97, 251 💬 |
217 |
Asb-683699 |
- |
- |
- |
- |
013 1件: 13 💬 |
218 |
Aspirin |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 11件: 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231 💬 |
219 |
Aspirin 650mg oral capsule |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
220 |
Ata188 |
- |
- |
- |
- |
013 1件: 13 💬 |
221 |
Atacicept |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 4件: 13, 46, 49, 66 💬 |
222 |
Atacicept 150 mg |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 2件: 13, 49 💬 |
223 |
Atacicept 25 mg |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 2件: 13, 66 💬 |
224 |
Atacicept 75 mg |
Atacicept |
1件: D09704 D09704 💬 |
TNFSF13 2件: TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 3件: 13, 49, 66 💬 |
225 |
Atg |
- |
- |
- |
- |
013 4件: 13, 60, 96, 285 💬 |
226 |
Atl1102 |
ATL1102 |
- |
- |
- |
013 1件: 13 💬 |
227 |
Atomoxetine |
Atomoxetine |
2件: D02574 D02574, D07473 D07473 💬 |
SLC6A2 1件: SLC6A2 💬 |
Synaptic vesicle cycle 1件: Synaptic vesicle cycle |
006 3件: 6, 8, 13 💬 |
228 |
Atorvastatin |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
229 |
Atx-ms-1467 |
- |
- |
- |
- |
013 1件: 13 💬 |
230 |
Aubagio |
- |
- |
- |
- |
013 1件: 13 💬 |
231 |
Aubagio - 14 mg - compressa rivestita con film - uso orale - blister (alu/alu) - 28 compresse |
- |
- |
- |
- |
013 1件: 13 💬 |
232 |
Aubagio® |
- |
- |
- |
- |
013 1件: 13 💬 |
233 |
Autologous adipose derived mesenchymal cells |
- |
- |
- |
- |
013 1件: 13 💬 |
234 |
Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved |
- |
- |
- |
- |
013 1件: 13 💬 |
235 |
Autologous bone marrow-derived mononuclear stem cells |
- |
- |
- |
- |
013 1件: 13 💬 |
236 |
Autologous cd4+t cells stimulated and expanded ex vivo by a mog peptide modified by the introduction of a thioreductase motif into the flanking residues of the t cell epitope |
- |
- |
- |
- |
013 1件: 13 💬 |
237 |
Autologous hematopoietic stem cell |
- |
- |
- |
- |
013 1件: 13 💬 |
238 |
Autologous hematopoietic stem cells |
- |
- |
- |
- |
013 1件: 13 💬 |
239 |
Autologous mesenchymal cell product |
- |
- |
- |
- |
013 1件: 13 💬 |
240 |
Autologous mesenchymal stem cell transplantation |
- |
- |
- |
- |
013 1件: 13 💬 |
241 |
Autologous mesenchymal stem cells |
- |
- |
- |
- |
002 5件: 2, 6, 13, 17, 46 💬 |
242 |
Autologous stem cells |
- |
- |
- |
- |
013 2件: 13, 51 💬 |
243 |
Autologous t-lymphocytes |
- |
- |
- |
- |
013 1件: 13 💬 |
244 |
Autologous vitd3 tolerogenic monocyte-derived dendritic cells loaded with a pool of myelin peptides (toldc-vitd3) |
- |
- |
- |
- |
013 1件: 13 💬 |
245 |
Av605 |
- |
- |
- |
- |
013 1件: 13 💬 |
246 |
Avonex |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
247 |
Avonex (interferon beta 1a) |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
248 |
Avonex (interferon beta-1a), biogen idec ltd |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
249 |
Avonex 30 microgram/0.5 ml solution for injection |
- |
- |
- |
- |
013 1件: 13 💬 |
250 |
Avonex 30 microgramos/0,5 ml (interferón beta - 1a) solución inyectable |
- |
- |
- |
- |
013 1件: 13 💬 |
251 |
Avonex 30 microgramos/0.5 ml solución para inyección |
- |
- |
- |
- |
013 1件: 13 💬 |
252 |
Avonex 30 µg/0,5 ml solution for injection |
- |
- |
- |
- |
013 1件: 13 💬 |
253 |
Avonex and topamax |
- |
- |
- |
- |
013 1件: 13 💬 |
254 |
Avonex im 4sir 30mcg/0,5ml 4ag |
- |
- |
- |
- |
013 1件: 13 💬 |
255 |
Avonex*im 4sir 30mcg/0,5ml+4ag |
- |
- |
- |
- |
013 1件: 13 💬 |
256 |
Avonex/betaseron/copaxone/rebif |
- |
- |
- |
- |
013 1件: 13 💬 |
257 |
Avonex/zocor |
- |
- |
- |
- |
013 1件: 13 💬 |
258 |
Avonex® |
- |
- |
- |
- |
013 1件: 13 💬 |
259 |
Avonex® monotherapy (6.0 miu administered i.m. each week) |
- |
- |
- |
- |
013 1件: 13 💬 |
260 |
Avp-923 |
- |
- |
- |
- |
002 3件: 2, 6, 13 💬 |
261 |
Azathioprine |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
006 20件: 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
262 |
Azathioprine (aza) |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
013 3件: 13, 19, 97 💬 |
263 |
Azatioprina |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
013 3件: 13, 96, 97 💬 |
264 |
Azatioprina hex. 50cpr 50mg bl |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
013 1件: 13 💬 |
265 |
Azithromycin |
Azithromycin |
3件: D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
013 6件: 13, 84, 85, 96, 228, 299 💬 |
266 |
Bacille calmette-guerin vaccine |
- |
- |
- |
- |
013 1件: 13 💬 |
267 |
Bacille of calmette-guerin |
- |
- |
- |
- |
013 1件: 13 💬 |
268 |
Baclofen |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
002 5件: 2, 10, 13, 18, 149 💬 |
269 |
Baclofen 20 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
270 |
Baclofen er capsules (grs) 10 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
271 |
Baclofen er capsules (grs) 20 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
272 |
Baclofen er capsules (grs) 30mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
273 |
Baclofen er capsules (grs) 40mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
274 |
Baclofen er capsules (grs) 50 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
275 |
Baclofen ir |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
276 |
Baclofen tablets usp |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
277 |
Baclofen tablets usp 10 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
278 |
Baf312 |
- |
- |
- |
- |
013 2件: 13, 50 💬 |
279 |
Baf312 0,25 mg tablet |
- |
- |
- |
- |
013 1件: 13 💬 |
280 |
Baf312 1 mg tablet |
- |
- |
- |
- |
013 2件: 13, 50 💬 |
281 |
Baf312 4 mg tablet |
- |
- |
- |
- |
013 1件: 13 💬 |
282 |
Baf312 hemifumarate |
- |
- |
- |
- |
013 2件: 13, 50 💬 |
283 |
Baf312a |
- |
- |
- |
- |
013 1件: 13 💬 |
284 |
Bafiertam |
- |
- |
- |
- |
013 1件: 13 💬 |
285 |
Balance |
Isoxaflutole |
- |
- |
- |
005 9件: 5, 6, 13, 46, 81, 113, 122, 149, 299 💬 |
286 |
Baminercept |
Baminercept |
1件: D08866 D08866 💬 |
LTB 1件: LTB 💬 |
Cytokine-cytokine receptor interaction 3件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 4件: 13, 46, 53, 97 💬 |
287 |
Baseline treatment |
- |
- |
- |
- |
013 1件: 13 💬 |
288 |
Bat4406f |
- |
- |
- |
- |
013 1件: 13 💬 |
289 |
Bay 79-4998 |
- |
- |
- |
- |
013 1件: 13 💬 |
290 |
Bay86-5046 |
- |
- |
- |
- |
013 1件: 13 💬 |
291 |
Bay86-5046_interferon-beta-1b |
- |
- |
- |
- |
013 1件: 13 💬 |
292 |
Bazedoxifene |
Bazedoxifene |
1件: D03062 D03062 💬 |
- |
- |
013 1件: 13 💬 |
293 |
Bazedoxifene acetate |
Acetate |
1件: D03062 D03062 💬 |
- |
- |
013 1件: 13 💬 |
294 |
Bbr 2778 |
- |
- |
- |
- |
011 2件: 11, 13 💬 |
295 |
Bcd-033 (interferon beta 1a) |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
296 |
Bcd-054 180 mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
297 |
Bcd-054 240 mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
298 |
Bcd-063 |
- |
- |
- |
- |
013 1件: 13 💬 |
299 |
Bcd-132 |
- |
- |
- |
- |
013 1件: 13 💬 |
300 |
Bcd-132, 125 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
301 |
Bcd-132, 500 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
302 |
Bcg20-0134 |
- |
- |
- |
- |
013 1件: 13 💬 |
303 |
Beam regimen |
- |
- |
- |
- |
013 1件: 13 💬 |
304 |
Beetainterferoni -1a |
- |
- |
- |
- |
013 1件: 13 💬 |
305 |
Behavioral: 6 months weight resistance and balance program |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
306 |
Behavioral: adherence counseling |
- |
- |
- |
- |
013 1件: 13 💬 |
307 |
Behavioral: assessment of disability |
- |
- |
- |
- |
013 1件: 13 💬 |
308 |
Behavioral: assessment of impact of ms on cognition |
- |
- |
- |
- |
013 1件: 13 💬 |
309 |
Behavioral: balance training |
Isoxaflutole |
- |
- |
- |
006 2件: 6, 13 💬 |
310 |
Behavioral: collaborative care (cc) |
- |
- |
- |
- |
013 1件: 13 💬 |
311 |
Behavioral: learning |
- |
- |
- |
- |
013 1件: 13 💬 |
312 |
Behavioral: medical marijuana |
Medical Cannabis |
- |
- |
- |
013 1件: 13 💬 |
313 |
Behavioral: meditation |
- |
- |
- |
- |
013 1件: 13 💬 |
314 |
Behavioral: motivational interviewing |
- |
- |
- |
- |
013 1件: 13 💬 |
315 |
Behavioral: physical activity together for pwms and their cgs (pat-ms) |
- |
- |
- |
- |
013 1件: 13 💬 |
316 |
Behavioral: self massage |
- |
- |
- |
- |
013 1件: 13 💬 |
317 |
Behavioral: step tracking |
- |
- |
- |
- |
013 1件: 13 💬 |
318 |
Behavioral: telephone-based cognitive behavioral therapy |
- |
- |
- |
- |
013 1件: 13 💬 |
319 |
Behavioral: water tracking |
Water |
1件: D00001 D00001 💬 |
- |
- |
013 1件: 13 💬 |
320 |
Best available therapy (bat) |
- |
- |
- |
- |
013 1件: 13 💬 |
321 |
Beta-1b interferoni |
- |
- |
- |
- |
013 1件: 13 💬 |
322 |
Beta-alanine |
Alanine |
2件: D00012 D00012, D07561 D07561 💬 |
- |
- |
013 1件: 13 💬 |
323 |
Beta-alanine supplementation |
Alanine |
2件: D00012 D00012, D07561 D07561 💬 |
- |
- |
013 1件: 13 💬 |
324 |
Beta-carotene |
Beta carotene |
1件: D03101 D03101 💬 |
- |
- |
013 1件: 13 💬 |
325 |
Beta-interferon |
- |
- |
- |
- |
013 1件: 13 💬 |
326 |
Betacarotene |
Beta carotene |
1件: D03101 D03101 💬 |
- |
- |
013 1件: 13 💬 |
327 |
Betaferon |
- |
- |
- |
- |
013 1件: 13 💬 |
328 |
Betaferon 250 mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
329 |
Betaferon 250 microgram/ml |
- |
- |
- |
- |
013 1件: 13 💬 |
330 |
Betaferon 250 microgram/ml, powder and solvent for solution for injection |
- |
- |
- |
- |
013 1件: 13 💬 |
331 |
Betaferon 250 microgram/ml, powder and solvent for solution for injection. |
- |
- |
- |
- |
013 1件: 13 💬 |
332 |
Betaferon 250 microgramos |
- |
- |
- |
- |
013 1件: 13 💬 |
333 |
Betaferon 250mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
334 |
Betaferon 250µg |
- |
- |
- |
- |
013 1件: 13 💬 |
335 |
Betaferon 500 mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
336 |
Betaferon 500 µg |
- |
- |
- |
- |
013 1件: 13 💬 |
337 |
Betaferon 500mcg |
- |
- |
- |
- |
013 1件: 13 💬 |
338 |
Betaferon 500µg |
- |
- |
- |
- |
013 1件: 13 💬 |
339 |
Betaferon sc 15f 0,25mg 15sir |
- |
- |
- |
- |
013 1件: 13 💬 |
340 |
Betaferon*15confez 0,25mg/ml+ |
- |
- |
- |
- |
013 1件: 13 💬 |
341 |
Betaferon, bay 86-5046 |
- |
- |
- |
- |
013 1件: 13 💬 |
342 |
Betaferon/betaseron |
- |
- |
- |
- |
013 1件: 13 💬 |
343 |
Betaferon® |
- |
- |
- |
- |
013 1件: 13 💬 |
344 |
Betaferon® (interferon beta-1b) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
345 |
Betaseron |
- |
- |
- |
- |
013 1件: 13 💬 |
346 |
Betaseron (interferon beta-1b, bay86-5046) |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
347 |
Betaseron (interferon beta-1b, bay86-5046), bayer healthcare ag |
Human interferon beta |
1件: D00746 D00746 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
348 |
Bevacizumab |
Bevacizumab |
1件: D06409 D06409 💬 |
VEGFA 1件: VEGFA 💬 |
AGE-RAGE signaling pathway in diabetic complications 22件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway |
013 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬 |
349 |
Bexarotene |
Bexarotene |
1件: D03106 D03106 💬 |
RXRA 3件: RXRA, RXRB, RXRG 💬 |
Adipocytokine signaling pathway 15件: Adipocytokine signaling pathway, Bile secretion, Gastric cancer, Hepatitis C, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer |
013 2件: 13, 75 💬 |
350 |
Bg-12 120 |
- |
- |
- |
- |
013 1件: 13 💬 |
351 |
Bg00002 |
- |
- |
- |
- |
013 1件: 13 💬 |
352 |
Bg00002 (natalizumab) |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
353 |
Bg00002-e (natalizumab high titer) |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
354 |
Bg00012 |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
355 |
Bg00012 (dmf) |
- |
- |
- |
- |
013 1件: 13 💬 |
356 |
Bg00012 (dmf) (tecfidera®.) |
- |
- |
- |
- |
013 1件: 13 💬 |
357 |
Bg0002 (natalizumab) |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 1件: 13 💬 |
358 |
Bg9418 (interferon beta 1-a) |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
359 |
Bg9418 (interferon beta-1a) |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 2件: 13, 97 💬 |
360 |
Bgc20-0134 |
- |
- |
- |
- |
013 1件: 13 💬 |
361 |
Bgg492 |
- |
- |
- |
- |
013 1件: 13 💬 |
362 |
Bht-3009 |
- |
- |
- |
- |
013 1件: 13 💬 |
363 |
Bht-3009 0.5 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
364 |
Bht-3009 1.5 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
365 |
Bht-3009-01 |
- |
- |
- |
- |
013 1件: 13 💬 |
366 |
Biib017 |
- |
- |
- |
- |
013 1件: 13 💬 |
367 |
Biib017 (peginterferon beta-1a) |
Peginterferon beta-1a |
1件: D10483 D10483 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
368 |
Biib019 |
- |
- |
- |
- |
013 1件: 13 💬 |
369 |
Biib019 (daclizumab high yield process) |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
370 |
Biib019 (daclizumab) |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
371 |
Biib033 |
- |
- |
- |
- |
013 1件: 13 💬 |
372 |
Biib033 (anti-lingo) |
- |
- |
- |
- |
013 1件: 13 💬 |
373 |
Biib033 (anti-lingo) - ev substance code sub118957 |
- |
- |
- |
- |
013 1件: 13 💬 |
374 |
Biib033 (opicinumab) |
Opicinumab |
1件: D11767 D11767 💬 |
- |
- |
013 1件: 13 💬 |
375 |
Biib041 |
- |
- |
- |
- |
013 1件: 13 💬 |
376 |
Biib041 (fampridine) |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
377 |
Biib041 (fampridine-sr) |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
378 |
Biib041 (pr fampridine) |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
379 |
Biib061 |
- |
- |
- |
- |
013 1件: 13 💬 |
380 |
Biib133 |
- |
- |
- |
- |
013 1件: 13 💬 |
381 |
Biotin |
Biotin |
1件: D00029 D00029 💬 |
- |
- |
002 5件: 2, 8, 10, 13, 20 💬 |
382 |
Biotina |
Biotin |
1件: D00029 D00029 💬 |
- |
- |
013 1件: 13 💬 |
383 |
Birt 2584 xx |
- |
- |
- |
- |
013 1件: 13 💬 |
384 |
Birt 2584xx |
- |
- |
- |
- |
013 1件: 13 💬 |
385 |
Bisacodyl |
Bisacodyl |
1件: D00245 D00245 💬 |
- |
- |
013 1件: 13 💬 |
386 |
Blood sample |
- |
- |
- |
- |
008 13件: 8, 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
387 |
Blood samples |
- |
- |
- |
- |
013 8件: 13, 41, 46, 51, 61, 97, 227, 271 💬 |
388 |
Blood sampling |
- |
- |
- |
- |
013 5件: 13, 17, 19, 51, 96 💬 |
389 |
Bmmnc |
- |
- |
- |
- |
013 1件: 13 💬 |
390 |
Bms 188667 (abatacept) |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
013 1件: 13 💬 |
391 |
Bone marrow autologous mesenchymal stem cells transplantation |
- |
- |
- |
- |
013 1件: 13 💬 |
392 |
Borage oil |
Borage oil |
- |
- |
- |
013 1件: 13 💬 |
393 |
Borage oil 20% gla |
Borage oil |
- |
- |
- |
013 1件: 13 💬 |
394 |
Bortezomib |
Bortezomib |
1件: D03150 D03150 💬 |
PSMB5 1件: PSMB5 💬 |
Alzheimer disease 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 15件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
395 |
Bosentan |
Bosentan |
2件: D01227 D01227, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 |
396 |
Boswelan |
- |
- |
- |
- |
013 1件: 13 💬 |
397 |
Boswellia serrata |
Indian frankincense |
- |
- |
- |
013 1件: 13 💬 |
398 |
Boswellia serrata extract |
Indian frankincense |
- |
- |
- |
013 1件: 13 💬 |
399 |
Boswellia serrata extract ps0201bo capsules |
Indian frankincense |
- |
- |
- |
013 1件: 13 💬 |
400 |
Boswellic acids (boswelan) |
- |
- |
- |
- |
013 1件: 13 💬 |
401 |
Botox |
- |
- |
- |
- |
002 6件: 2, 6, 13, 51, 149, 226 💬 |
402 |
Botox® |
- |
- |
- |
- |
013 1件: 13 💬 |
403 |
Botulinum toxin |
- |
- |
- |
- |
006 3件: 6, 13, 149 💬 |
404 |
Botulinum toxin a |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
013 4件: 13, 51, 149, 226 💬 |
405 |
Botulinum toxin a - haemagglutinin complex |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
013 1件: 13 💬 |
406 |
Botulinum toxin type a |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
002 10件: 2, 5, 6, 7, 13, 15, 17, 70, 113, 149 💬 |
407 |
Botulinum toxin type a 200u |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
013 1件: 13 💬 |
408 |
Botulinum toxin type a 300u |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
013 1件: 13 💬 |
409 |
Botulinum toxin type a infiltrations |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
013 1件: 13 💬 |
410 |
Brimonidine |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 2件: 13, 90 💬 |
411 |
Brimonidine tartrate |
Brimonidine |
2件: D02076 D02076, D07540 D07540 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 2件: 13, 90 💬 |
412 |
Bx-1 |
- |
- |
- |
- |
013 1件: 13 💬 |
413 |
C1-esterase inhibitor (cinryze) |
- |
- |
- |
- |
013 1件: 13 💬 |
414 |
C105 |
- |
- |
- |
- |
013 1件: 13 💬 |
415 |
Caffeine |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 9件: 2, 6, 13, 21, 46, 78, 96, 97, 265 💬 |
416 |
Calcio |
Calcium |
- |
- |
- |
013 1件: 13 💬 |
417 |
Calcio folinato dc.it |
Calcium |
- |
- |
- |
013 1件: 13 💬 |
418 |
Calcium |
Calcium |
- |
- |
- |
006 27件: 6, 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
419 |
Calcium and vitamin d combination |
Calcium |
- |
- |
- |
013 1件: 13 💬 |
420 |
Calcium carbonate |
Calcium |
2件: D00932 D00932, D10802 D10802 💬 |
- |
- |
013 8件: 13, 19, 46, 53, 75, 96, 235, 299 💬 |
421 |
Calcium levofolinate |
Calcium |
- |
- |
- |
013 1件: 13 💬 |
422 |
Cannabidiol |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 17件: 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬 |
423 |
Cannabidiol / dronabinol capsule 5 mg+2,5 mg |
Cannabidiol |
2件: D00306 D00306, D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 1件: 13 💬 |
424 |
Cannabidiol botanical drug substance (cbd bds) |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 1件: 13 💬 |
425 |
Cannabidiol capsule 5 mg |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 1件: 13 💬 |
426 |
Cannabis |
Medical Cannabis |
- |
- |
- |
002 8件: 2, 6, 13, 46, 90, 96, 97, 271 💬 |
427 |
Cannabis based medicine extract (sativex) |
Medical Cannabis |
- |
- |
- |
013 1件: 13 💬 |
428 |
Cannabis, medical |
Medical Cannabis |
- |
- |
- |
002 5件: 2, 6, 13, 96, 97 💬 |
429 |
Cannador |
- |
- |
- |
- |
013 1件: 13 💬 |
430 |
Caprylic triglyceride |
Tricaprylin |
- |
- |
- |
013 1件: 13 💬 |
431 |
Capsules with 160 mg teavigo (at least 94% egcg) |
Epigallocatechin gallate |
- |
- |
- |
013 1件: 13 💬 |
432 |
Carbamazepine |
Carbamazepine |
1件: D00252 D00252 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 2件: 13, 231 💬 |
433 |
Carbidopa |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 9件: 2, 4, 6, 13, 17, 90, 140, 164, 201 💬 |
434 |
Carbonate |
Carbonate ion |
- |
- |
- |
002 12件: 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
435 |
Carmustine |
Carmustine |
1件: D00254 D00254 💬 |
- |
- |
011 5件: 11, 13, 14, 28, 60 💬 |
436 |
Carmustine, etoposide, cytarabine, and melphalan (beam) |
Carmustine |
7件: D00125 D00125, D00168 D00168, D00254 D00254, D00369 D00369, D03046 D03046, D03637 D03637, D04107 D04107 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
013 1件: 13 💬 |
437 |
Carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 8件: 5, 13, 58, 96, 97, 265, 298, 316 💬 |
438 |
Carnosine |
Carnosine |
- |
- |
- |
006 2件: 6, 13 💬 |
439 |
Carnosine, capsulle, 2 g/day, 8 weeks |
Carnosine |
- |
- |
- |
013 1件: 13 💬 |
440 |
Cbd |
- |
- |
- |
- |
002 11件: 2, 6, 8, 13, 46, 140, 144, 145, 156, 158, 206 💬 |
441 |
Cc |
- |
- |
- |
- |
013 13件: 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271 💬 |
442 |
Cci-779 |
- |
- |
- |
- |
013 2件: 13, 46 💬 |
443 |
Cdp323 |
CDP323 |
- |
- |
- |
013 1件: 13 💬 |
444 |
Cellcept |
- |
- |
- |
- |
011 5件: 11, 13, 42, 43, 49 💬 |
445 |
Cellular therapy with ebv specific autologous ctl infusion |
- |
- |
- |
- |
013 1件: 13 💬 |
446 |
Ceralifimod |
Ceralifimod |
- |
- |
- |
013 1件: 13 💬 |
447 |
Ceralifmod |
- |
- |
- |
- |
013 1件: 13 💬 |
448 |
Cesamet™ (nabilone) |
Nabilone |
1件: D05099 D05099 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 1件: 13 💬 |
449 |
Ceterizine |
- |
- |
- |
- |
013 1件: 13 💬 |
450 |
Cetirizina |
Cetirizine |
2件: D00664 D00664, D07662 D07662 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
451 |
Cetirizina mylan generics |
Cetirizine |
2件: D00664 D00664, D07662 D07662 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
452 |
Cetirizine |
Cetirizine |
2件: D00664 D00664, D07662 D07662 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 2件: 13, 35 💬 |
453 |
Cetirizine hydrochloride |
Cetirizine |
2件: D00664 D00664, D07662 D07662 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
454 |
Cgp 77116 |
- |
- |
- |
- |
013 1件: 13 💬 |
455 |
Charcoal |
- |
- |
- |
- |
013 1件: 13 💬 |
456 |
Chloride |
Chloride ion |
- |
- |
- |
006 25件: 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
457 |
Cholecalciferol |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 9件: 13, 19, 34, 46, 49, 96, 97, 298, 299 💬 |
458 |
Cholecalciferol (vitamin d3) |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 2件: 13, 299 💬 |
459 |
Cholecalciferol, vitamin d3 |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 1件: 13 💬 |
460 |
Cholestyramine |
Cholestyramine |
- |
- |
- |
013 2件: 13, 79 💬 |
461 |
Chr-1103 / gbr500 |
- |
- |
- |
- |
013 1件: 13 💬 |
462 |
Cianocobalamina |
Cyanocobalamin |
4件: D00166 D00166, D03615 D03615, D03616 D03616, D03617 D03617 💬 |
- |
- |
013 1件: 13 💬 |
463 |
Cianocobalamina fu dc.it |
Cyanocobalamin |
4件: D00166 D00166, D03615 D03615, D03616 D03616, D03617 D03617 💬 |
- |
- |
013 1件: 13 💬 |
464 |
Ciclofosfamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
013 1件: 13 💬 |
465 |
Cinryze |
- |
- |
- |
- |
013 2件: 13, 61 💬 |
466 |
Circadin |
- |
- |
- |
- |
006 3件: 6, 13, 90 💬 |
467 |
Circadin ( inn= melatonin) |
Melatonin |
1件: D08170 D08170 💬 |
MTNR1A 2件: MTNR1A, MTNR1B 💬 |
Circadian entrainment 2件: Circadian entrainment, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
468 |
Cisapride |
Cisapride |
2件: D00274 D00274, D02092 D02092 💬 |
HTR2A 3件: HTR2A, HTR3A, HTR4 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
469 |
Citalopram |
Citalopram |
2件: D00822 D00822, D07704 D07704 💬 |
SLC6A4 1件: SLC6A4 💬 |
Serotonergic synapse 2件: Serotonergic synapse, Synaptic vesicle cycle |
006 6件: 6, 8, 13, 18, 46, 127 💬 |
470 |
Citochine ed immunomodulatori |
- |
- |
- |
- |
013 1件: 13 💬 |
471 |
Cladribina |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
472 |
Cladribina oral |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
473 |
Cladribine |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 2件: 13, 94 💬 |
474 |
Cladribine 3.5 mg/kg |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
475 |
Cladribine 5.25 mg/kg |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
476 |
Cladribine oral tablet |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
477 |
Cladribine tablet |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
478 |
Cladribine tablets |
Cladribine |
1件: D01370 D01370 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
479 |
Clemastine |
Clemastine |
2件: D00666 D00666, D03535 D03535 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
480 |
Clemastine fumarate |
Clemastine |
2件: D00666 D00666, D03535 D03535 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
481 |
Clostridium botulinum |
Clostridium botulinum |
- |
- |
- |
013 1件: 13 💬 |
482 |
Clostridium botulinum toxin type a |
Botulinum toxin type A |
1件: D00783 D00783 💬 |
SNAP25 1件: SNAP25 💬 |
Insulin secretion 2件: Insulin secretion, Synaptic vesicle cycle |
013 1件: 13 💬 |
483 |
Cnm-au8 |
- |
- |
- |
- |
002 2件: 2, 13 💬 |
484 |
Cnp-ms-0601 |
- |
- |
- |
- |
013 1件: 13 💬 |
485 |
Cnto 1275 |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
486 |
Co |
- |
- |
- |
- |
006 5件: 6, 13, 53, 70, 85 💬 |
487 |
Co-14 |
- |
- |
- |
- |
013 1件: 13 💬 |
488 |
Coconut |
Coconut |
- |
- |
- |
013 2件: 13, 53 💬 |
489 |
Coconut oil |
Coconut |
1件: D05326 D05326 💬 |
- |
- |
013 1件: 13 💬 |
490 |
Coconut oil and epigallocatechin gallate |
Coconut |
1件: D05326 D05326 💬 |
- |
- |
013 1件: 13 💬 |
491 |
Coenzyme q |
- |
- |
- |
- |
013 1件: 13 💬 |
492 |
Colecalciferol |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 4件: 13, 46, 96, 228 💬 |
493 |
Colecalciferol concentrate (oily form) |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 1件: 13 💬 |
494 |
Combination product: ofatumumab with ai |
Ofatumumab |
1件: D09314 D09314 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
495 |
Combination product: ofatumumab with prf |
Ofatumumab |
1件: D09314 D09314 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
013 1件: 13 💬 |
496 |
Cop |
- |
- |
- |
- |
013 1件: 13 💬 |
497 |
Cop-1 |
Glatiramer |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
498 |
Cop-1/copolymer-1 |
Glatiramer |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
499 |
Copaxone |
- |
- |
- |
- |
013 1件: 13 💬 |
500 |
Copaxone - 20 mg/ml soluzione iniettabile in siringhe preriempite 30 siringhe |
- |
- |
- |
- |
013 1件: 13 💬 |
501 |
Copaxone - 40 mg/ml soluzione iniettabile in siringa preriempita 12 siringhe preriempite da 1 ml con ago |
- |
- |
- |
- |
013 1件: 13 💬 |
502 |
Copaxone 20 mg |
- |
- |
- |
- |
013 1件: 13 💬 |
503 |
Copaxone 20 mg/ml |
- |
- |
- |
- |
013 1件: 13 💬 |
504 |
Copaxone 20 mg/ml solución inyectable en jeringa precargada |
- |
- |
- |
- |
013 1件: 13 💬 |
505 |
Copaxone 20 mg/ml solución para inyección en jeringa precargada |
- |
- |
- |
- |
013 1件: 13 💬 |
506 |
Copaxone 20 mg/ml solution for injection, pre-filled syringe |
- |
- |
- |
- |
013 1件: 13 💬 |
507 |
Copaxone 20 mg/ml, solution for injection, pre-filled syringes |
- |
- |
- |
- |
013 1件: 13 💬 |
508 |
Copaxone 20mg/ml solution for injection, pre-filled syringe |
- |
- |
- |
- |
013 1件: 13 💬 |
509 |
Copaxone 40 mg/ml |
- |
- |
- |
- |
013 1件: 13 💬 |
510 |
Copaxone 40 mg/ml solution for injection, pre-filled syringe |
- |
- |
- |
- |
013 1件: 13 💬 |
511 |
Copaxone subcutaneous injection syringe |
- |
- |
- |
- |
013 1件: 13 💬 |
512 |
Copaxone*sc 28sir 20mg/ml |
- |
- |
- |
- |
013 1件: 13 💬 |
513 |
Copaxone-teva |
- |
- |
- |
- |
013 1件: 13 💬 |
514 |
Copaxone® |
- |
- |
- |
- |
013 1件: 13 💬 |
515 |
Copolymer 1 |
- |
- |
- |
- |
013 1件: 13 💬 |
516 |
Copolymer-1 |
Glatiramer |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
517 |
Corticosteroid |
- |
- |
- |
- |
013 10件: 13, 42, 43, 44, 45, 66, 84, 96, 97, 222 💬 |
518 |
Corticosteroids & tancart19/20 |
- |
- |
- |
- |
013 1件: 13 💬 |
519 |
Corticotropin |
Corticotropin |
1件: D00146 D00146 💬 |
MC2R 1件: MC2R 💬 |
Aldosterone synthesis and secretion 5件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 7件: 2, 13, 46, 75, 78, 84, 222 💬 |
520 |
Cranberry |
Cranberry |
- |
- |
- |
013 1件: 13 💬 |
521 |
Creatine |
Creatine |
- |
- |
- |
001 12件: 1, 2, 5, 6, 8, 13, 46, 49, 50, 113, 156, 201 💬 |
522 |
Cs-0777 tablets |
- |
- |
- |
- |
013 1件: 13 💬 |
523 |
Ct103a cells |
- |
- |
- |
- |
013 1件: 13 💬 |
524 |
Curcumin |
Curcumin |
- |
- |
- |
002 11件: 2, 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 💬 |
525 |
Cyclophosfamide |
- |
- |
- |
- |
013 1件: 13 💬 |
526 |
Cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
527 |
Cyclophosphamide (drug) |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
013 1件: 13 💬 |
528 |
Cyclophosphamide and atg |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
013 1件: 13 💬 |
529 |
Cyclophosphamide and fludarabine |
Cyclophosphamide |
4件: D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 1件: 13 💬 |
530 |
Cyclophosphamide monohydrate |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
013 4件: 13, 60, 96, 256 💬 |
531 |
Cyclophosphamide/glatiramer acetate |
Acetate |
3件: D00287 D00287, D04318 D04318, D07760 D07760 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 1件: 13 💬 |
532 |
Cymbalta |
- |
- |
- |
- |
006 3件: 6, 13, 49 💬 |
533 |
Cysteine |
Cysteine |
2件: D00026 D00026, D02326 D02326 💬 |
- |
- |
006 11件: 6, 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬 |
534 |
Cytarabine |
Cytarabine |
3件: D00168 D00168, D03046 D03046, D03637 D03637 💬 |
- |
- |
011 6件: 11, 13, 14, 25, 49, 60 💬 |
535 |
Cytolytic cd4+ t cells |
- |
- |
- |
- |
013 1件: 13 💬 |
536 |
Cápsulas de laquinimod 0.6 mg |
Laquinimod |
- |
- |
- |
013 1件: 13 💬 |
537 |
Células madre mesenquimales |
- |
- |
- |
- |
013 1件: 13 💬 |
538 |
D mannose |
Mannose |
- |
- |
- |
013 1件: 13 💬 |
539 |
D-aspartate |
- |
- |
- |
- |
013 1件: 13 💬 |
540 |
D-biotin |
Biotin |
1件: D00029 D00029 💬 |
- |
- |
010 3件: 10, 13, 20 💬 |
541 |
D-biotina |
Biotin |
1件: D00029 D00029 💬 |
- |
- |
013 1件: 13 💬 |
542 |
Dac |
- |
- |
- |
- |
013 3件: 13, 90, 301 💬 |
543 |
Dac hyp |
- |
- |
- |
- |
013 1件: 13 💬 |
544 |
Dac-hyp |
- |
- |
- |
- |
013 1件: 13 💬 |
545 |
Daclizumab |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 7件: 13, 56, 60, 65, 97, 283, 284 💬 |
546 |
Daclizumab (anti-cd25 humanized monoclonal antibody) |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
547 |
Daclizumab high yield process |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
548 |
Daclizumab hyp |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
549 |
Daclizumab hyp (dac hyp |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
550 |
Daclizumab hyp (dac hyp) |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
551 |
Daclizumab wih greek suffix |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
552 |
Daclizumab with greek suufix |
Daclizumab |
1件: D03639 D03639 💬 |
IL2RA 1件: IL2RA 💬 |
Cytokine-cytokine receptor interaction 11件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor |
013 1件: 13 💬 |
553 |
Dalfampridine |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
004 2件: 4, 13 💬 |
554 |
Dalfampridine er |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
555 |
Dalfampridine-er 10mg |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
556 |
Dalfampridine-er 5mg |
Dalfampridine |
1件: D04127 D04127 💬 |
KCNA4 4件: KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 1件: 13 💬 |
557 |
Dantrolene |
Dantrolene |
2件: D02274 D02274, D02347 D02347 💬 |
- |
- |
013 2件: 13, 233 💬 |
558 |
Dapirolizumab pegol |
Dapirolizumab pegol |
- |
- |
- |
013 2件: 13, 49 💬 |
559 |
Darifenacin |
Darifenacin |
2件: D01699 D01699, D03654 D03654 💬 |
CHRM3 1件: CHRM3 💬 |
Alzheimer disease 11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
006 2件: 6, 13 💬 |
560 |
Darifenacin (bay79-4998) |
Darifenacin |
2件: D01699 D01699, D03654 D03654 💬 |
CHRM3 1件: CHRM3 💬 |
Alzheimer disease 11件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction |
013 1件: 13 💬 |
561 |
Dc-tab |
- |
- |
- |
- |
013 1件: 13 💬 |
562 |
Dekristol |
- |
- |
- |
- |
013 2件: 13, 97 💬 |
563 |
Dekristol 20000 ie |
- |
- |
- |
- |
013 1件: 13 💬 |
564 |
Dekristol® 400-tabletten |
- |
- |
- |
- |
013 1件: 13 💬 |
565 |
Dekristol®-tablette 1 (400 ie) |
- |
- |
- |
- |
013 1件: 13 💬 |
566 |
Delta-9-tetrahydrocannabinol |
Dronabinol |
1件: D00306 D00306 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
008 2件: 8, 13 💬 |
567 |
Demestril septem |
- |
- |
- |
- |
013 1件: 13 💬 |
568 |
Device: 2 ma transcranial direct current stimulation |
- |
- |
- |
- |
013 1件: 13 💬 |
569 |
Device: 4 ma transcranial direct current stimulation |
- |
- |
- |
- |
013 1件: 13 💬 |
570 |
Device: avonex prefilled syringe via manual im injection |
- |
- |
- |
- |
013 1件: 13 💬 |
571 |
Device: balance platform therapy |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
572 |
Device: betaconnect |
- |
- |
- |
- |
013 1件: 13 💬 |
573 |
Device: betaconnect auto-injector |
- |
- |
- |
- |
013 1件: 13 💬 |
574 |
Device: betaconnect auto-injector. |
- |
- |
- |
- |
013 1件: 13 💬 |
575 |
Device: betaconnect autoinjector |
- |
- |
- |
- |
013 1件: 13 💬 |
576 |
Device: betaconnect device |
- |
- |
- |
- |
013 1件: 13 💬 |
577 |
Device: biib017 (peginterferon beta-1a) autoinjector |
Peginterferon beta-1a |
1件: D10483 D10483 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
578 |
Device: biib017 (peginterferon beta-1a) pre-filled syringe (pfs) |
Peginterferon beta-1a |
1件: D10483 D10483 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
579 |
Device: capacity of muscular oxygen extraction |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
013 1件: 13 💬 |
580 |
Device: cic using lofric primo |
- |
- |
- |
- |
013 1件: 13 💬 |
581 |
Device: dynamic vessel analyzer (dva) |
- |
- |
- |
- |
013 1件: 13 💬 |
582 |
Device: extracorporeal photopheresis |
- |
- |
- |
- |
013 1件: 13 💬 |
583 |
Device: four-point cane (fpc) |
- |
- |
- |
- |
013 1件: 13 💬 |
584 |
Device: fourier domain doppler optical coherence tomography (fdoct) |
- |
- |
- |
- |
013 1件: 13 💬 |
585 |
Device: interferon beta-1a |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
586 |
Device: lokomat training |
- |
- |
- |
- |
013 1件: 13 💬 |
587 |
Device: magnetic resonance imaging |
- |
- |
- |
- |
006 5件: 6, 13, 22, 34, 299 💬 |
588 |
Device: medication event monitoring system (mems) |
- |
- |
- |
- |
013 1件: 13 💬 |
589 |
Device: metabolic fatigue |
- |
- |
- |
- |
013 1件: 13 💬 |
590 |
Device: mybetaapp |
- |
- |
- |
- |
013 1件: 13 💬 |
591 |
Device: neuromuscular electrical stimulation delivered using the electrical therapy device empi 300 pv |
- |
- |
- |
- |
013 1件: 13 💬 |
592 |
Device: nintendo wii fit balance board |
Isoxaflutole |
- |
- |
- |
013 1件: 13 💬 |
593 |
Device: nirs after bosentan administration |
Bosentan |
2件: D01227 D01227, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
594 |
Device: nirs baseline |
- |
- |
- |
- |
013 1件: 13 💬 |
595 |
Device: optical coherence tomography (oct) |
- |
- |
- |
- |
013 1件: 13 💬 |
596 |
Device: optical coherence tomography angiography (octa) |
- |
- |
- |
- |
013 1件: 13 💬 |
597 |
Device: paired associative stimulation (pas) |
- |
- |
- |
- |
013 1件: 13 💬 |
598 |
Device: repetitive transcranial magnetic stimulation (rtms) |
- |
- |
- |
- |
013 1件: 13 💬 |
599 |
Device: sham transcranial direct current stimulation (tdcs) |
- |
- |
- |
- |
013 1件: 13 💬 |
600 |
Device: single-point cane (spc) |
- |
- |
- |
- |
013 1件: 13 💬 |
601 |
Device: single-pulse transcranial magnetic stimulation (sptms) |
- |
- |
- |
- |
013 1件: 13 💬 |
602 |
Device: single-use autoinjector |
- |
- |
- |
- |
013 1件: 13 💬 |
603 |
Device: single-use autoinjector with a prefilled liquid avonex syringe |
- |
- |
- |
- |
013 1件: 13 💬 |
604 |
Device: sleep assessment |
- |
- |
- |
- |
013 1件: 13 💬 |
605 |
Device: tcd after bosentan administration |
Bosentan |
2件: D01227 D01227, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
606 |
Device: tcd baseline |
- |
- |
- |
- |
013 1件: 13 💬 |
607 |
Device: transcranial magnetic stimulation (tms) |
- |
- |
- |
- |
013 1件: 13 💬 |
608 |
Device: trekking pole (tp). |
- |
- |
- |
- |
013 1件: 13 💬 |
609 |
Device: video game therapy |
- |
- |
- |
- |
013 1件: 13 💬 |
610 |
Device: wristband physical activity monitor |
Methamidophos |
- |
- |
- |
013 1件: 13 💬 |
611 |
Dexamethason |
- |
- |
- |
- |
013 4件: 13, 28, 46, 331 💬 |
612 |
Dexamethasone |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
613 |
Dexamethasone soduim phosphate |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
614 |
Dexchlorpheniramine |
Dexchlorpheniramine |
1件: D07803 D07803 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
013 1件: 13 💬 |
615 |
Dexrazoxane |
Dexrazoxane |
1件: D03730 D03730 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
013 1件: 13 💬 |
616 |
Dexrazoxane (drz) plus mitoxantrone (mx) |
Dexrazoxane |
3件: D02166 D02166, D03730 D03730, D08224 D08224 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
013 1件: 13 💬 |
617 |
Dextromethorphan |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 11件: 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 💬 |
618 |
Dextromethorphan hydrobromide |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
013 2件: 13, 46 💬 |
619 |
Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 2件: 2, 13 💬 |
620 |
Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 2件: 2, 13 💬 |
621 |
Dextromethorphan/quinidine |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
622 |
Dextrometorfano |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
013 1件: 13 💬 |
623 |
Dextrometorfano hidrobromuro |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
013 1件: 13 💬 |
624 |
Dextrometorfano/quinidina |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
625 |
Diagnostic test: entire-body pet-ct scans |
- |
- |
- |
- |
013 1件: 13 💬 |
626 |
Diagnostic test: oral glucose tolerance test |
Dextrose, unspecified form |
- |
- |
- |
013 3件: 13, 65, 299 💬 |
627 |
Diagnostic test: pet with [11c]flumazenil |
Flumazenil |
1件: D00697 D00697 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
013 1件: 13 💬 |
628 |
Diagnostic test: stroop test |
- |
- |
- |
- |
013 1件: 13 💬 |
629 |
Diagnostic test: testing of autonomous nervous system function |
- |
- |
- |
- |
013 1件: 13 💬 |
630 |
Diazoxide |
Diazoxide |
1件: D00294 D00294 💬 |
ABCC8 2件: ABCC8, KCNJ11 💬 |
ABC transporters 4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
013 2件: 13, 193 💬 |
631 |
Dibase |
- |
- |
- |
- |
013 1件: 13 💬 |
632 |
Diclofenac |
Diclofenac |
3件: D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associat |